Biomedical Technologies For information about our Biomedical technologies you can contact: Lori Dars Marketing Specialist Phone: 732-932-0115 x3004 Email: dars@ocltt.rutgers.edu

Available technologies

To download a summary of the technology in Adobe PDF format. Please click a link below:

• New variants of reverse transcriptase enzyme from HIV to be used in high-throughput protein crystallography to enhance structure based drug design
• Methods and Compositions for the diagnosis and treatment of schizophrenia
• Antibiotic Drug Discovery
• Novel small-molecule anti cancer agent
• Automated Rodent Testing Apparatus
• Using CYPIN in Assays, Diagnostics and Treatment Of Cognitive Disorders
• A Novel Role for Snapin in Dendrite Patterning: Interaction with Cypin
• Elevation of Glutamate transporters in glia to treat SCI and pain
• Gene silencing with U1 adaptors
• G-Quadraplex Stabilizers
• Site-Specific release of chemotherapeutica agents to thwart chemotoxicity
• Spray-on Wound Dressing

Select Research Presentations of Commercially Viable Technologies:

• Metabotropic glutamate receptor 1 (Grm1) - Dr. Suzie Chen
• New Antibiotics discovery - Dr. Richard Ebright
• Discovery of Novel Drugs from Marine Organisms - Dr. Paul G. Falkowski
• Cypin: Drug Target for Cognitive Disorders - Dr. Firestein
• RSE - A Method for region specific DNA extraction - Dr. Gabriel
• U1 Adaptor. A new potent gene silencing technology by Dr. Gunderson.
• Improving Cancer Chemotherapy through the Design of Targeted Prodrugs of Known Anticancer Agents - Dr. Longqin Hu.
• Quantitative Image based Morphometric Analysis - Dr. Anant Madabhushi
• Multifunctional Nanolipoblockers - Dr. Prabhas Moghe
• Pterostilbene from Blueberries for Colon Cancer Prevention - Dr. Suh